Omeros(OMER) - 2025 Q4 - Earnings Call Transcript

Omeros (NasdaqGM:OMER) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Company ParticipantsBrandon Folkes - Managing DirectorDavid Borges - Chief Accounting OfficerGreg Demopulos - Chairman and CEOJennifer Williams - PrincipalNadia Dac - Chief Commercial OfficerSerge Belanger - Managing Director of BioPharma Equity ResearchSteve Brozak - President and Managing PartnerConference Call ParticipantsSam Rodriguez - Biotech Equity Research AnalystOperatorPlease be advised that this call is being recorded at the ...